REYKJAVIK, Iceland, July 19, 2021 /PRNewswire/ -- In a paper published in Nature genetics today, Scientists from deCODE genetics, a fully owned subsidiary of Amgen, report sequence variants that ...

Scientists at deCODE genetics, a subsidiary of Amgen, have published a study in Nature Communications, comparing over 110 thousand patients with autoimmune thyroid disease (AITD) from Iceland ...

REYKJAVIK, Iceland, Jan. 29, 2024 /PRNewswire/ -- Scientists at deCODE genetics, a subsidiary of Amgen, and their collaborators from Iceland, Denmark, and the USA published a study today in Nature ...

Amgen subsidiary deCODE Genetics has identified new risk factors and genes associated with clonal hematopoiesis, a precursor state to blood cancer.

News about deCODE Genetics, Incorporated, including commentary and archival articles published in The New York Times.

DeCode scientists reported yesterday that people who inherit two copies of the gene – one from each parent – are more than twice as likely to develop diabetes as those who don’t carry any copies.

Amgen, the world's largest biotech company by revenue, and deCODE, based in Reykjavik, Iceland, announced the all-cash deal Monday. DeCODE, founded in 1996, has discovered genetic risk factors for ...

Now, a large international study led by deCODE Genetics (a subsidiary of Amgen) provides novel insights into the biology of migraine enabling detection of rare variants protecting against migraine ...